Here are Tuesday’s biggest calls on Wall Street:
Bank of America reiterates Micron as buy
The firm raised its price target on Micron to $1,500 per share from $950.
“We maintain our bullish views for AI memory, supported by robust demand and limited supplies through CY26-28.”
Susquehanna initiates SpaceX as neutral
The firm said investors should wait for a better entry point.
“We are initiating coverage of Space Exploration Technologies Corporation (SPCX) with a Neutral rating and price target of $170.”
Bernstein reiterates Nvidia and Broadcom as outperform
Bernstein says both stocks are a must-own.
“Own both NVDA and AVGO. We get the desire to play the bottlenecks instead, but they
won’t ultimately work if these don’t; in the meantime demand shows no signs of slowing, and both stocks screen unreasonably cheap.”
Baird reiterates Tesla as outperform
Baird said it’s sticking with Tesla and sees a SpaceX merger “sooner rather than later.”
“With the deal now complete, we believe focus will shift to a potential merger between the two entities, and we see this as likely to happen sooner rather than later. Acknowledging uncertainty in the timing of a potential merger, we continue to be buyers of TSLA with company-specific catalysts ahead”
Bernstein reiterates Netflix as outperform
Bernstein said the stock will be volatile but that it’s sticking with Netflix.
“The debate continues over whether well-understood near-term challenges could become more permanent. While these pressures are materializing as expected, unnecessary speculations aren’t helping, especially given the lack of near-term catalysts.”
JPMorgan upgrades IBM to overweight from neutral
JPMorgan said it sees “software acceleration.”
“We are upgrading to Overweight with greater confidence in a 2H′26 CC software acceleration following a deeper look at IBM’s software business.”
Piper Sandler upgrades Synopsys to overweight from neutral
Piper said in its upgrade Synopsys that it sees a recovery.
“We are raising our PT to $550 from $450 based on a.) higher growth estimates, b.) slightly higher profitability estimates, and c.) higher terminal multiple based on the anticipated recovery in the IP segment and resulting improvement in top line growth.
Evercore ISI downgrades Nike to in line from outperform
Evercore said the turnaround will take time.
“Nike’s always been a big battleship to turn, but ~2-years into the turnaround our checks are still picking up unexpected new resets lower in the wholesale channel minimal needle moving innovation in the pipeline into CY27, and near-term execution issues.”
RBC initiates GE HealthCare as outperform
RBC said it sees accelerating growth for GE HealthCare
“GEHC’s increased R&D investments and commercial execution post its 2023 spin from General Electric is driving order momentum with a strong backlog that positions it for accelerated growth starting later in 2026 towards its long-range plan.”
Comments